PeptideDB

Ofatumumab

CAS No.: 679818-59-8

Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation
molecular weight 149 kDa
CAS 679818-59-8
Storage store at low temperature | store at -20°C
References 1. Barth MJ, et al.Ofatumumab Exhibits Enhanced In Vitro and In Vivo Activity Compared to Rituximab in Preclinical Models of Mantle Cell Lymphoma.Clin Cancer Res. 2015 Oct 1;21(19):4391-7.